News

Compared to the standard shot, the mRNA vaccine had an overall vaccine efficacy that was 26.6 percent higher, and 27.4 ...
Moderna Inc. said Monday its experimental flu shot showed positive results in a late-stage trial.   In a Phase 3 study, the ...
Moderna said on Monday its influenza vaccine was found to be 26.6% more effective than an approved annual flu shot from GSK ...
Moderna Inc. said its experimental flu shot met its goal in a late-stage trial, clearing the path for its broader strategy of ...
October is the prime time to get a flu vaccine to protect yourself through the worst of the respiratory season. However, keep your expectations in check. This year’s shot may be less effectiv… ...
A federal vaccine advisory panel voted this week to recommend significant updates to the nation’s respiratory syncytial virus (RSV) and influenza vaccination policies, signaling a new direction ...
FluMist vaccine vs. flu shot The FluMist vaccine, manufactured by AstraZeneca, was approved in 2003 for health care providers to give patients, but the method has gotten renewed attention due to a ...
DAYTON, Ohio (WDTN) — As flu season nears, a survey from the Ohio State University found just under half of Americans do not plan on getting the flu shot. “It is a potentially very serious ...
Many Americans have not gotten either a flu shot or updated COVID-19 vaccine. Just over half of U.S. adults (53%) say they’ve gotten neither the flu shot nor the updated COVID-19 vaccine since last ...
News; Nation; Flu shot may not be as effective as last year, but it’s still worth getting Oct. 15, 2024 Updated Tue., Oct. 15, 2024 at 12:26 p.m. A woman arrives at a CVS pharmacy past a sign ...
How to stay healthy during the holidays 04:33. If you still haven't gotten your COVID or flu shot, don't fret – experts say it's the perfect time to get vaccinated before the holidays are in ...
Moderna Inc. said Monday its experimental flu shot showed positive results in a late-stage trial. In a Phase 3 study, the company’s mRNA-1010 flu vaccine’s efficacy was nearly 27 percent ...